With M&A activity in the medtech industry at a 15-year low (in terms of number of deals), it's refreshing to see more acquisitions being announced in the second half of the year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,